Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.346
-0.054 (-1.23%)
Oct 26, 2026, 2:20 PM EDT - Market open
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of $248.51 million as of October 26, 2026. It is the 19,243rd most valuable company in the world and the 3,360th biggest in the United States. Its market cap has decreased by 11.56% in one year.
Market Cap
248.51M
Enterprise Value
121.56M
1-Year Change
-11.56%
Global Rank
Country Rank
#3,360 United States
Category
ChartMarket Cap Chart
Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $248.51M, an increase of 218.60%. That is a compound annual growth rate of 4.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 248.51M | -12.99% |
| Dec 31, 2025 | 285.60M | 17.97% |
| Dec 31, 2024 | 242.10M | 95.08% |
| Dec 29, 2023 | 124.10M | 134.59% |
| Dec 30, 2022 | 52.90M | 54.23% |
| Dec 31, 2021 | 34.30M | -77.83% |
| Dec 31, 2020 | 154.70M | -7.53% |
| Dec 31, 2019 | 167.30M | -51.12% |
| Dec 31, 2018 | 342.30M | -53.83% |
| Dec 29, 2017 | 741.40M | 282.56% |
| Dec 30, 2016 | 193.80M | 76.18% |
| Dec 31, 2015 | 110.00M | 5,689.47% |
| Dec 31, 2014 | 1.90M | -70.31% |
| Dec 31, 2013 | 6.40M | 10.34% |
| Dec 31, 2012 | 5.80M | -82.63% |
| Dec 30, 2011 | 33.40M | -15.87% |
| Dec 31, 2010 | 39.70M | -7.89% |
| Dec 31, 2009 | 43.10M | 563.08% |
| Dec 31, 2008 | 6.50M | -43.97% |
| Dec 31, 2007 | 11.60M | 17.17% |
| Dec 29, 2006 | 9.90M | 7.61% |
| Dec 30, 2005 | 9.20M | -83.24% |
| Dec 31, 2004 | 54.90M | -21.57% |
| Dec 31, 2003 | 70.00M | 255.33% |
| Dec 31, 2002 | 19.70M | -65.50% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 259.22M |
| SAB Biotherapeutics | 258.40M |
| Q32 Bio | 257.51M |
| Lineage Cell Therapeutics | 252.91M |
| Fate Therapeutics | 252.82M |
| Clinuvel Pharmaceuticals | 252.53M |
| Rocket Pharmaceuticals | 251.38M |
| Ocugen | 250.84M |